Axxcess Wealth Management LLC boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS – Get Rating) by 13.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,329 shares of the company’s stock after purchasing an additional 382 shares during the period. Axxcess Wealth Management LLC’s holdings in Zoetis were worth $572,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. American National Bank increased its holdings in Zoetis by 469.2% during the 2nd quarter. American National Bank now owns 148 shares of the company’s stock valued at $25,000 after purchasing an additional 122 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC increased its holdings in Zoetis by 430.8% during the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 138 shares of the company’s stock valued at $26,000 after purchasing an additional 112 shares during the period. Worth Asset Management LLC purchased a new position in Zoetis during the 1st quarter valued at about $26,000. Aurora Private Wealth Inc. purchased a new position in Zoetis during the 2nd quarter valued at about $36,000. Finally, Capital Wealth Alliance LLC purchased a new position in Zoetis during the 2nd quarter valued at about $45,000. Hedge funds and other institutional investors own 91.05% of the company’s stock.
Wall Street Analyst Weigh In
ZTS has been the topic of a number of research analyst reports. Morgan Stanley reduced their target price on Zoetis from $264.00 to $248.00 and set an “overweight” rating on the stock in a report on Tuesday, November 15th. The Goldman Sachs Group reduced their target price on Zoetis from $207.00 to $180.00 and set a “buy” rating on the stock in a report on Friday, November 4th. JPMorgan Chase & Co. reduced their target price on Zoetis from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Monday, October 17th. StockNews.com initiated coverage on Zoetis in a report on Wednesday, October 12th. They set a “buy” rating on the stock. Finally, William Blair reiterated an “outperform” rating on shares of Zoetis in a report on Thursday, November 3rd. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $215.17.
Zoetis Stock Performance
Zoetis (NYSE:ZTS – Get Rating) last released its quarterly earnings data on Thursday, November 3rd. The company reported $1.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.24 by ($0.03). The business had revenue of $2 billion during the quarter, compared to the consensus estimate of $2.08 billion. Zoetis had a net margin of 25.82% and a return on equity of 48.41%. The business’s revenue was up .6% compared to the same quarter last year. During the same period last year, the company posted $1.25 earnings per share. On average, equities research analysts predict that Zoetis Inc. will post 4.87 earnings per share for the current fiscal year.
Zoetis Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 1st. Investors of record on Tuesday, November 1st will be given a $0.325 dividend. The ex-dividend date is Monday, October 31st. This represents a $1.30 annualized dividend and a yield of 0.86%. Zoetis’s dividend payout ratio (DPR) is presently 29.68%.
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
- Get a free copy of the StockNews.com research report on Zoetis (ZTS)
- Three CBD Stocks to Dominate a Budding Industry
- Is the 60/40 Portfolio Mix Still in Vogue?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Microsoft Shares: Is it Time to Back Up the Truck?
- Institutional Support for Analog Devices Remains High
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.